[NMR screening in fragment-based drug discovery]

Area of Science:

• Nuclear magnetic resonance (NMR) spectroscopy and its applications in pharmaceutical research.

Context:

• NMR is a versatile technique with applications ranging from organic chemistry to medical imaging (MRI).
• Biomolecular NMR is crucial for determining biomolecular structures and analyzing protein-inhibitor interactions.
• In fragment-based drug discovery (FBDD), NMR excels at detecting weakly binding compounds.

Purpose:

• To review the application of NMR techniques in pharmaceutical research, focusing on fragment screening.
• To differentiate between ligand-based and protein-based NMR screening methods.
• To highlight the advantages of ligand-based techniques in FBDD.

Summary:

• NMR fragment screening is broadly categorized into ligand-based and protein-based techniques.
• Protein-based methods require stable isotope-labeled proteins and are suitable for smaller targets.
• Ligand-based methods (e.g., Saturation Transfer Difference (STD) and Water-Ligand Observation with Gradient Spectroscopy (WaterLOGSY)) observe only ligand signals, making them efficient for primary screening due to lower protein consumption, despite potential non-specific binding requiring further validation.

Impact:

• NMR techniques, especially ligand-based approaches, are instrumental in accelerating the early stages of drug discovery.
• The ability of NMR to accurately detect weak binding interactions facilitates the identification of novel drug leads.
• Understanding the nuances of different NMR screening strategies optimizes resource allocation and improves hit identification rates in FBDD.